Omnicell (OMCL) Gross Margin (2010 - 2026)
Omnicell's (OMCL) quarterly Gross Margin came in at 48.98% in Q2 2026, up 504.0% year-over-year from 8.11% in Q2 2025, and up 8.14% quarter-over-quarter from 45.3% in Q1 2026.
Analysis
Omnicell (OMCL) Gross Margin (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Gross Margin for 17 consecutive years, with 48.98% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Gross Margin rose 504.0% year-over-year to 48.98% in Q2 2026; TTM through Jun 2026 was 44.77%, a 104.0% increase from a year earlier, with the FY2025 full-year figure at 42.49%, up 14.0% from the prior year.
- Gross Margin was 48.98% for Q2 2026 at Omnicell, up from 45.3% in the prior quarter.
- Over five years, Gross Margin peaked at 48.98% in Q2 2026 and troughed at 37.63% in Q1 2024.
- A 5-year average of 43.71% and a median of 43.62% in 2025 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin plunged 710 bps in 2022 and surged 547 bps in 2024, its largest moves.
- Over 5 years, Gross Margin stood at 40.9% in 2022, then decreased by 0 bps to 40.72% in 2023, then advanced by 13 bps to 46.19% in 2024, then fell by 10 bps to 41.51% in 2025, then advanced by 18 bps to 48.98% in 2026.
- The last three Gross Margin figures came in at 48.98% (Q2 2026), 45.3% (Q1 2026), and 41.51% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 57.71% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 67.78% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 64.99% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 68.27% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 70.71% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 77.46% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 60.21% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 63.44% |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 58.84% |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 48.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48.98% |
| Mar 31, 2026 | 45.30% |
| Dec 31, 2025 | 41.51% |
| Sep 30, 2025 | 43.30% |
| Jun 30, 2025 | 43.94% |
| Mar 31, 2025 | 41.14% |
| Dec 31, 2024 | 46.19% |
| Sep 30, 2024 | 43.29% |
| Jun 30, 2024 | 41.31% |
| Mar 31, 2024 | 37.63% |
| Dec 31, 2023 | 40.72% |
| Sep 30, 2023 | 44.18% |
| Jun 30, 2023 | 44.97% |
| Mar 31, 2023 | 43.02% |
| Dec 31, 2022 | 40.90% |
| Sep 30, 2022 | 45.71% |
| Jun 30, 2022 | 47.71% |
| Mar 31, 2022 | 47.06% |
| Dec 31, 2021 | 48.00% |
| Sep 30, 2021 | 49.52% |